CASI Pharmaceuticals, Inc Earning Date (CASI)

USA |NASDAQ |USD

CASI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $-0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $7.16M

Casi Pharmaceuticals, Inc's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

CASI Earnings Date & History Chart

CASI Earnings & Revenue Forecast

CASI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-0.22 $-0.29 $-0.12

CASI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.22 $-0.21 $-0.29

CASI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $37.48M $27.70M $44.90M

CASI Earnings Date & Revenue History

CASI Earnings History

|
Show More
Show More

CASI Revenue History

|
Show More
Show More

Casi Pharmaceuticals, Inc Next Earnings Date & Report

CASI Next Earnings Date & Report Preview: Jun 2022 (FQ)

CASI's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Casi Pharmaceuticals, Inc Previous Earnings Dates & Reports

CASI Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Casi Pharmaceuticals, Inc's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.

CASI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Casi Pharmaceuticals, Inc's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

CASI's earnings per share (EPS) was $-0.44, missing the consensus analysts forecast of $-0.36 by 22.22% , and higher than the previous year's EPS (Dec 2019) by -8.33%.

Revenues were $15.14M, better than the forecast of $14.70M by 3.00%, and up by 266.52% from previous year's revenue.

The company reported a net income of $-48.29M.

Casi Pharmaceuticals, Inc reported a free cash flow of $-45.21M for its fiscal year, compared to $-37.26M a year ago.

The company ended the fiscal year with $1.29M in total debt, a decrease of -41.30% compared to the previous year.